Feng Chi Biotech Corp. (TPEX:6744)
16.70
-0.10 (-0.60%)
At close: Apr 24, 2026
Feng Chi Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.39 | 26.25 | 30.61 | 65.9 | 48.81 |
Short-Term Investments | 160.74 | 180.93 | 185.32 | 169 | 181.47 |
Cash & Short-Term Investments | 178.13 | 207.18 | 215.93 | 234.9 | 230.27 |
Cash Growth | -14.02% | -4.06% | -8.08% | 2.01% | 5.03% |
Accounts Receivable | 15.33 | 15.92 | 14.92 | 11.54 | 12.61 |
Receivables | 15.33 | 15.92 | 14.92 | 11.54 | 12.61 |
Inventory | 34.73 | 19.05 | 19.04 | 25.46 | 20.33 |
Prepaid Expenses | 3.44 | 3.27 | 3.17 | 0.85 | 1.16 |
Other Current Assets | 0.96 | 0.91 | 2.15 | 2.47 | 1.67 |
Total Current Assets | 232.59 | 246.32 | 255.21 | 275.22 | 266.03 |
Property, Plant & Equipment | 32.88 | 32.53 | 27.24 | 24.29 | 13.42 |
Long-Term Investments | 14.56 | 12.78 | 11.33 | - | - |
Other Intangible Assets | 0.11 | 0.02 | 0.07 | 0.13 | 0.01 |
Long-Term Deferred Tax Assets | 1.69 | 1.51 | 1.67 | 1.63 | 1.72 |
Other Long-Term Assets | 6.08 | 5.92 | 5.52 | 7.1 | 5.51 |
Total Assets | 287.91 | 299.07 | 301.03 | 308.36 | 286.69 |
Accounts Payable | 14.24 | 17.07 | 12.94 | 18.78 | 14.9 |
Accrued Expenses | 6.48 | 6.21 | 8.08 | 9.3 | 8.59 |
Current Portion of Leases | 2.8 | 2.72 | 2.65 | 2.58 | 2.55 |
Current Income Taxes Payable | 0.66 | 0.18 | 1.71 | 2.33 | 2.17 |
Current Unearned Revenue | 17.14 | 22.29 | 24.17 | 25.24 | 23.97 |
Other Current Liabilities | 3.9 | 5.13 | 5.25 | 3.3 | 4 |
Total Current Liabilities | 45.21 | 53.59 | 54.8 | 61.53 | 56.18 |
Long-Term Leases | 2.63 | 5.43 | 8.15 | 10.8 | - |
Long-Term Deferred Tax Liabilities | 0.17 | 0.18 | 0.09 | 0.16 | - |
Total Liabilities | 48.01 | 59.19 | 63.03 | 72.49 | 56.18 |
Common Stock | 154 | 154 | 154 | 154 | 154 |
Additional Paid-In Capital | 30.05 | 30.05 | 30.05 | 30.05 | 30.05 |
Retained Earnings | 54.09 | 54.24 | 53.82 | 51.82 | 46.45 |
Comprehensive Income & Other | 1.76 | 1.58 | 0.13 | - | - |
Shareholders' Equity | 239.9 | 239.88 | 238 | 235.87 | 230.51 |
Total Liabilities & Equity | 287.91 | 299.07 | 301.03 | 308.36 | 286.69 |
Total Debt | 5.43 | 8.15 | 10.8 | 13.38 | 2.55 |
Net Cash (Debt) | 172.7 | 199.03 | 205.13 | 221.53 | 227.72 |
Net Cash Growth | -13.23% | -2.98% | -7.40% | -2.72% | 6.42% |
Net Cash Per Share | 11.18 | 12.87 | 13.27 | 14.32 | 14.73 |
Filing Date Shares Outstanding | 15.4 | 15.4 | 15.4 | 15.4 | 15.4 |
Total Common Shares Outstanding | 15.4 | 15.4 | 15.4 | 15.4 | 15.4 |
Working Capital | 187.38 | 192.74 | 200.41 | 213.69 | 209.85 |
Book Value Per Share | 15.58 | 15.58 | 15.45 | 15.32 | 14.97 |
Tangible Book Value | 239.8 | 239.86 | 237.93 | 235.74 | 230.5 |
Tangible Book Value Per Share | 15.57 | 15.58 | 15.45 | 15.31 | 14.97 |
Machinery | 52.92 | 40.5 | 30.25 | 30.41 | 26 |
Leasehold Improvements | 0.11 | 0.11 | 0.11 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.